Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy for Patients with Locally Advanced Non-small Cell Lung Cancer: A Phase I Trial-Reference-Cited by-同舟云学术

Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy for Patients with Locally Advanced Non-small Cell Lung Cancer: A Phase I Trial

Published:2010-09 Issue:9 Volume:5 Page:1391-1396
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Heinzerling John H.,Choy Hak,Hughes Randall S.,Govindan Ramaswamy,Bradley Jeffrey D.,Schwartzberg Lee S.,Peng Guangbin,Treat Joseph,Tran Taylor,Obasaju Coleman

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference21 articles.

1. Concomitant radio-chemotherapy (RT-CT) versus sequential RT-CT in locally advanced non-small cell lung cancer (NSCLC). A meta-analysis using individual patient data from randomised clinical trials;Auperin;J Thorac Oncol,2007

2. Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer;Blackstock;J Clin Oncol,2007

3. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

4. LY231514, a novel pyrrolopyrimidine antifolate that inhibits thymidylate synthase (TS) [abstract];Grindey;Proc Am Assoc Cancer Res,1992

5. Structure-activity relationship studies of novel pyrrolopyrimidine antifolate LY231514 [abstract];Shih;Proc Am Assoc Cancer Res,1992

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A network meta-analysis for efficacies and toxicities of different concurrent chemoradiotherapy regimens in the treatment of locally advanced non-small cell lung cancer;BMC Cancer;2022-06-20

2. PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer;Journal of Clinical Oncology;2016-03-20

3. Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non–Small Cell Lung Cancer;Clinical Lung Cancer;2016-03

4. Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: A systematic review of completed and ongoing studies;Lung Cancer;2015-03

5. Phase 2 Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favorable-Prognosis Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer;Journal of Thoracic Oncology;2013-10